The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
TRIM5 is an innate immune sensor for the retrovirus capsid lattice
Open accessAbstract
TRIM5 is a RING domain-E3 ubiquitin ligase that restricts infection by human immunodeficiency virus (HIV)-1 and other retroviruses immediately following virus invasion of the target cell cytoplasm. Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice and several reports indicate that TRIM5 has a role in signal transduction, but the precise mechanism of restriction is unknown. Here we demonstrate that TRIM5 promotes innate immune signalling and that this activity is amplified by retroviral infection and interaction with the capsid lattice. Acting with the heterodimeric, ubiquitin-conjugating enzyme UBC13-UEV1A (also known as UBE2N-UBE2V1), TRIM5 catalyses the synthesis of unattached K63-linked ubiquitin chains that activate the TAK1 (also known as MAP3K7) kinase complex and stimulate AP-1 and NFκB signalling. Interaction with the HIV-1 capsid lattice greatly enhances the UBC13-UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NF-κB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid. Finally, TAK1 and UBC13-UEV1A contribute to capsid-specific restriction by TRIM5. Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signalling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In DCs, TRIM5α binding to the capsid lattice also triggers signal transduction cascades resulting in the activation of the transcription factors AP-1 and NF-κB 59.”
From Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis (2013) · cites this paper as [59]
The cited source says what the claim attributes to it.
In the citing paper
“Although this is insufficient to induce IFN production alone, these cascades synergize with other pathways, thus enhancing the IFN response 59.”
From Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis (2013) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M. H., Owens, C. M., Perron, M. J., Kießling, M. K., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,810
Integration of murine leukemia virus DNA depends on mitosis.
Roe, T., Reynolds, T. C., Yu, G., & Brown, P. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05858.x · Cited by 921
Stremlau, M. H., Perron, M. J., Lee, M. N., Li, Y., Song, B., Javanbakht, H., Diaz‐Griffero, F., Anderson, D. J., Sundquist, W. I., & Sodroski, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509996103 · Cited by 736
Assembly and Analysis of Conical Models for the HIV-1 Core
Ganser, B. K., Li, S., Klishko, V. Y., Finch, J. T., & Sundquist, W. I. (1999) · Science · doi:10.1126/science.283.5398.80 · Cited by 671
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
Sayah, D. M., Sokolskaja, E., Berthoux, L., & Luban, J. (2004) · Nature · doi:10.1038/nature02777 · Cited by 662
Self-citationAn Atomic Model of the Interferon-β Enhanceosome
Panne, D., Maniatis, T., & Harrison, S. C. (2007) · Cell · doi:10.1016/j.cell.2007.05.019 · Cited by 625
Zeng, W., Sun, L., Jiang, X., Chen, X., Hou, F., Adhikari, A., Xu, M., & Chen, Z. J. (2010) · Cell · doi:10.1016/j.cell.2010.03.029 · Cited by 613
Direct activation of protein kinases by unanchored polyubiquitin chains
Xia, Z.-P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., & Chen, Z. J. (2009) · Nature · doi:10.1038/nature08247 · Cited by 570
X-Ray Structures of the Hexameric Building Block of the HIV Capsid
Pornillos, O., Ganser-Pornillos, B. K., Kelly, B. N., Hua, Y., Whitby, F. G., Stout, C. D., Sundquist, W. I., Hill, C. P., & Yeager, M. (2009) · Cell · doi:10.1016/j.cell.2009.04.063 · Cited by 523
Yan, N., Regalado-Magdos, A. D., Stiggelbout, B., Lee‐Kirsch, M. A., & Lieberman, J. (2010) · Nature Immunology · doi:10.1038/ni.1941 · Cited by 522
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 648
Reddi, T. S., Merkl, P., Lim, S., Letvin, N. L., & Knipe, D. M. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009281 · Cited by 25
Coroadinha, A. S. (2023) · Cells · doi:10.3390/cells12050732 · Cited by 26
TRIM5α and TRIM22 Are Differentially Regulated According to HIV-1 Infection Phase and Compartment
Singh, R., Patel, V. B., Mureithi, M., Naranbhai, V., Ramsuran, D., Tulsi, S., Hiramen, K., Werner, L., Mlisana, K. P., Altfeld, M. A., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03603-13 · Cited by 25
Self-citationTRIM5 and the Regulation of HIV-1 Infectivity
Luban, J. (2012) · Molecular Biology International · doi:10.1155/2012/426840 · Cited by 28
Self-citationJosupeit, R., Bender, S., Kern, S., Leuchs, B., Hielscher, T., Herold‐Mende, C. C., Schlehofer, J. R., Dinsart, C., Witt, O., Rommelaere, J., et al. (2016) · Viruses · doi:10.3390/v8050138 · Cited by 25
Pizzato, M., McCauley, S. M., Neagu, M. R., Pertel, T., Firrito, C., Ziglio, S., Dauphin, A., Zufferey, M., Berthoux, L., & Luban, J. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005050 · Cited by 23
Self-citationPeng, C., Zhao, C., Wang, P., Yan, L. E., Fan, S., & Qiu, L. (2021) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2021.104169 · Cited by 24
Qu, Z.-L., Li, Y., Gong, X.-Y., Zhao, X., Sun, H.-Y., Dan, C., Gui, J., & Zhang, Y.-B. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200343 · Cited by 24
IP6‐stabilised HIV capsids evade cGAS/STING‐mediated host immune sensing
Papa, G., Albecka, A., Mallery, D. L., Vaysburd, M., Renner, N., & James, L. C. (2023) · EMBO Reports · doi:10.15252/embr.202256275 · Cited by 26
Wu, F., Ourmanov, I., Riddick, N. E., Matsuda, K., Whitted, S., Plishka, R. J., Buckler-White, A. J., Starost, M. F., & Hirsch, V. M. (2014) · Journal of Virology · doi:10.1128/jvi.02978-14 · Cited by 24
Structure–Activity Relationships of a Novel Capsid Targeted Inhibitor of HIV-1 Replication
Kortagere, S., Xu, J. P., Mankowski, M. K., Ptak, R. G., & Cocklin, S. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500437r · Cited by 24
Medrano, L. M., Rallón, N. I., Berenguer, J., Jiménez‐Sousa, M. Á., Soriano, V., Aldámiz‐Echevarría, T., Fernández‐Rodríguez, A., García, M., Tejerina, F., Martínez, I., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1005-7 · Cited by 24
de Pablo-Maiso, L., Doménech, A., Echeverría, I., Gómez-Arrebola, C., de Andrés, D., Rosati, S., Gómez‐Lucía, E., & Reina, R. (2018) · Viruses · doi:10.3390/v10080435 · Cited by 25
Preclinical Assessment of Mutant Human TRIM5α as an Anti-HIV-1 Transgene
Jung, U., Urak, K., Veillette, M., Nepveu-Traversy, M.-É., Pham, Q. T., Hamel, S., Rossi, J. J., & Berthoux, L. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.059 · Cited by 23
Viral and cellular mechanisms of the innate immune sensing of HIV
Lahaye, X., & Manel, N. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.01.013 · Cited by 26
Boso, G., Shaffer, E., Liu, Q., Cavanna, K., Buckler-White, A. J., & Kozak, C. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-47720-5 · Cited by 23
The role of TRIM proteins in PRR signaling pathways and immune-related diseases
Jin, Z., & Zhu, Z. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107813 · Cited by 23
Regulation of Viral Restriction by Post-Translational Modifications
Chamontin, C., Bossis, G., Nisole, S., Arhel, N. J., & Maarifi, G. (2021) · Viruses · doi:10.3390/v13112197 · Cited by 25
Siddiqui, M. A., & Yamashita, M. (2021) · mBio · doi:10.1128/mbio.02817-21 · Cited by 23
Pawlica, P., Sage, V. L., Poccardi, N., Tremblay, M. J., Mouland, A. J., & Berthoux, L. (2014) · Journal of Virology · doi:10.1128/jvi.03717-13 · Cited by 23
Virus-Specific Effects of TRIM5α rh RING Domain Functions on Restriction of Retroviruses
Li, X., Kim, J., Song, B., Finzi, A., Pacheco, B., & Sodroski, J. (2013) · Journal of Virology · doi:10.1128/jvi.00620-13 · Cited by 23
In Silico Analysis of Functional Single Nucleotide Polymorphisms in the Human TRIM22 Gene
Kelly, J. N., & Barr, S. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101436 · Cited by 23
Uev1A-Ubc13 catalyzes K63-linked ubiquitination of RHBDF2 to promote TACE maturation
Zhang, Y., Li, Y., Yang, X. S., Wang, J., Wang, R., Qian, X., Zhang, W., & Xiao, W. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.10.013 · Cited by 23
Investigating genetic drivers of dermatomyositis pathogenesis using meta-analysis
Aljabban, J., Syed, S. A., Syed, S., Rohr, M., Weisleder, N. L., McElhanon, K. E., Hasan, L. K., Safeer, L. Z., Hoffman, K. P., Aljabban, N., et al. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04866 · Cited by 23
Weber, F. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.002 · Cited by 24
An overview of intracellular interactions between immunodeficiency viruses and their hosts
Bieniasz, P. D. (2012) · AIDS · doi:10.1097/qad.0b013e328353bd04 · Cited by 22
Evidence for selection at HIV host susceptibility genes in a West Central African human population
Zhao, K. X., Ishida, Y., Oleksyk, T. K., Winkler, C. A., & Roca, A. L. (2012) · BMC Evolutionary Biology · doi:10.1186/1471-2148-12-237 · Cited by 22
Nakayama, E. E., & Shioda, T. (2015) · AIDS · doi:10.1097/qad.0000000000000812 · Cited by 24
Chen, Y., Cao, S., Sun, Y., & Li, C. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.12.008 · Cited by 22
Chadwick, L., Gentle, L., Strachan, J., & Layfield, R. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01236.x · Cited by 22
Hepatitis B Virus Nucleocapsid but Not Free Core Antigen Controls Viral Clearance in Mice
Lin, Y., Wu, H., Chen, D., & Chen, P. (2012) · Journal of Virology · doi:10.1128/jvi.00608-12 · Cited by 22
Forlani, G., Tosi, G., Turrini, F., Poli, G., Vicenzi, E., & Accolla, R. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00564 · Cited by 22
Role of Human TRIM5α in Intrinsic Immunity
Nakayama, E. E., & Shioda, T. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00097 · Cited by 22
SERINC proteins potentiate antiviral type I IFN production and proinflammatory signaling pathways
Zeng, C., Waheed, A. A., Li, T., Yu, J., Zheng, Y.-M., Yount, J. S., Wen, H., Freed, E. O., & Liu, S. (2021) · Science Signaling · doi:10.1126/scisignal.abc7611 · Cited by 25
The conserved sumoylation consensus site in TRIM5α modulates its immune activation functions
Nepveu-Traversy, M.-É., & Berthoux, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.02.013 · Cited by 21
Shi, J., Friedman, D. B., & Aiken, C. (2013) · Journal of Virology · doi:10.1128/jvi.00713-13 · Cited by 21
Kimsa, M. W., Strzałka‐Mrozik, B., Kimsa, M. C., Mazurek, U. M., Kruszniewska‐Rajs, C., Gola, J. M., Adamska, J., & Twardoch, M. (2014) · Folia Biologica · doi:10.14712/fb2014060030144 · Cited by 21
Mackelprang, R. D., Bamshad, M. J., Chong, J. X., Hou, X., Buckingham, K. J., Shively, K. M., de Bruyn, G., Mugo, N., Mullins, J. I., McElrath, M. J., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006703 · Cited by 21
TRIM39R, but not TRIM39B, regulates type I interferon response
Kurata, R., Tajima, A., Yonezawa, T., & Inoko, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.064 · Cited by 21
Bartels, H., & Luban, J. (2014) · Retrovirology · doi:10.1186/preaccept-8755229871261499 · Cited by 22
Self-citationUnconventional posttranslational modification in innate immunity
Chen, J., Qi, D., Hu, H., Wang, X., & Lin, W. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05319-8 · Cited by 21
Chan, E., Schaller, T., Eddaoudi, A., Zhan, H., Tan, C. P., Jacobsen, M. C., Thrasher, A. J., Towers, G. J., & Qasim, W. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.083 · Cited by 20
Mamede, J. I., Damond, F., de Bernardo, A., Matheron, S., Descamps, D., Battini, J., Sitbon, M., & Courgnaud, V. (2017) · Scientific Reports · doi:10.1038/srep45214 · Cited by 22
Latifi, T., Zebardast, A., & Marashi, S. M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103318 · Cited by 20
Tripartite Motif Protein Family in Central Nervous System Diseases
Pan, M., Li, X., Xu, G., Tian, X., Li, Y., & Fang, W. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01337-5 · Cited by 19
High level of susceptibility to human TRIM5α conferred by HIV-2 capsid sequences
Takeuchi, J. S., Perche, B., Migraine, J., Mercier‐Delarue, S., Ponscarme, D., Simon, F., Clavel, F., & Labrosse, B. (2013) · Retrovirology · doi:10.1186/1742-4690-10-50 · Cited by 20
Ali, S. A., Teow, S., Omar, M. T. C., Khoo, A. S. B., Choon, T. S., & Yusoff, N. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145986 · Cited by 20
Coadministration of a Plasmid Encoding HIV-1 Gag Enhances the Efficacy of Cancer DNA Vaccines
Lambricht, L., Vanvarenberg, K., Beuckelaer, A. D., Hoecke, L. V., Grooten, J., Učakar, B., Lipnik, P., Sanders, N. N., Lienenklaus, S., Véronique Préat, A., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.122 · Cited by 21
The Human Immunodeficiency Virus Capsid Is More Than Just a Genome Package
James, L. C., & Jacques, D. A. (2018) · Annual Review of Virology · doi:10.1146/annurev-virology-092917-043430 · Cited by 18
Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid
Sultana, T., Mamede, J. I., Saito, A., Ode, H., Nohata, K., Cohen, R., Nakayama, E. E., Iwatani, Y., Yamashita, M., Hope, T. J., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00986-19 · Cited by 20
Choi, U. Y., Hur, J. Y., Lee, M. S., Zhang, Q., Choi, W. Y., Kim, L. K., Lee, W., Oh, G. T., & Kim, Y.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095805 · Cited by 20
Hashimoto, M., Nasser, H., Chihara, T., & Suzu, S. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.233 · Cited by 20
Anti-HIV-1 activity of Trim 37
Tabah, A. A., Tardif, K. D., & Mansky, L. M. (2013) · Journal of General Virology · doi:10.1099/vir.0.057653-0 · Cited by 19
Morphogenesis of the Infectious HIV-1 Virion
Sakuragi, J.-I. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00242 · Cited by 21
Ubiquitination and SUMOylation in HIV Infection: Friends and Foes
Colomer-Lluch, M., Castro‐Gonzalez, S., & Serra-Moreno, R. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.035.159 · Cited by 21
Herpesvirus-mediated stabilization of ICP0 expression neutralizes restriction by TRIM23
Liu, X., Acharya, D., Krawczyk, E., Kangas, C., Gack, M. U., & He, B. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113060118 · Cited by 19
Hu, J.-X., Song, L., Ning, M., Niu, X., Han, M., Gao, C.-Z., Feng, X., Cai, H., Li, T., Li, F., et al. (2024) · BMC Biology · doi:10.1186/s12915-024-01817-0 · Cited by 15
de Matos, A. L., van der Loo, W., Areal, H., Lanning, D. K., & Esteves, P. J. (2011) · BMC Evolutionary Biology · doi:10.1186/1471-2148-11-294 · Cited by 19
Structure of a Spumaretrovirus Gag Central Domain Reveals an Ancient Retroviral Capsid
Ball, N. J., Nicastro, G., Dutta, M., Pollard, D. J., Goldstone, D. C., Sanz-Ramos, M., Ramos, A., Müllers, E., Stirnnagel, K., Stanke, N., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005981 · Cited by 19
TRIM5α Promotes Ubiquitination of Rta from Epstein–Barr Virus to Attenuate Lytic Progression
Huang, H.-H., Chen, C.-S., Wang, W., Hsu, S.-W., Tsai, H., Liu, S., & Chang, L.-K. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02129 · Cited by 19
TBK1 is ubiquitinated by TRIM5α to assemble mitophagy machinery
Saha, B., Olsvik, H. L., Williams, G. L., Oh, S., Evjen, G., Sjøttem, E., & Mandell, M. A. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114294 · Cited by 20
Anti-HIV Factors: Targeting Each Step of HIV's Replication Cycle
Colomer-Lluch, M., Gollahon, L., & Serra-Moreno, R. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224094621 · Cited by 17
Lupták, J., Mallery, D. L., Jahun, A. S., Albecka, A., Clift, D., Ather, O., Slodkowicz, G., Goodfellow, I., & James, L. C. (2022) · Viruses · doi:10.3390/v14081610 · Cited by 18
Ingram, Z., Kline, C. E., Hughson, A. K., Singh, P. K., Fischer, H. L., Radhakrishnan, R., Sowd, G. A., dos Santos, N. F. B., Ganser‐Pornillos, B. K., Watkins, S. C., et al. (2025) · mBio · doi:10.1128/mbio.00169-25 · Cited by 16
The role of tripartite motif family members in mediating susceptibility to HIV-1 infection
Rahm, N., & Telenti, A. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835048e1 · Cited by 20
Cellular and Biochemical Mechanisms of the Retroviral Restriction Factor SAMHD1
Wu, L. J. (2013) · ISRN Biochemistry · doi:10.1155/2013/728392 · Cited by 19
Interactomic analysis reveals a homeostatic role for the HIV restriction factor TRIM5α in mitophagy
Saha, B., Salemi, M., Williams, G. L., Oh, S., Paffett, M. L., Phinney, B. S., & Mandell, M. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110797 · Cited by 18
Mu, D., Yang, H., Zhu, J.-W., Liu, F., Tian, R., Zheng, H., Han, J.-B., Shi, P., & Zheng, Y. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu238 · Cited by 18
A Potent Postentry Restriction to Primate Lentiviruses in a Yinpterochiropteran Bat
Morrison, J. H., Miller, C. M., Bankers, L., Crameri, G. S., Wang, L., & Poeschla, E. M. (2020) · mBio · doi:10.1128/mbio.01854-20 · Cited by 20
Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid
Boswell, M. T., & Rowland‐Jones, S. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13280 · Cited by 18
Nef, the shuttling molecular adaptor of HIV, influences the cytokine network
Percario, Z. A., Ali, M., Mangino, G., & Affabris, E. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.010 · Cited by 17
Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3
Sutter, K., Francois, S., Sigmund, A. M., Harper, M. S., Barrett, B. S., Kirchning, C. J., Lu, M., Santiago, M. L., & Dittmer, U. (2014) · Retrovirology · doi:10.1186/s12977-014-0126-4 · Cited by 17
Positive Regulation of TRAF6-Dependent Innate Immune Responses by Protein Phosphatase PP1-γ
Opaluch, A. M., Schneider, M., Chiang, C.-Y., Nguyen, Q., Maestre, A. M., Mulder, L. C. F., Secundino, I., Jesus, P. D. D., König, R., Simon, V. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089284 · Cited by 17
Biard‐Piechaczyk, M., Borel, S., Espert, L., de Bettignies, G., & Coux, O. (2011) · Biology of the Cell · doi:10.1111/boc.201100112 · Cited by 18
The novel gene TRIM44L from orange-spotted grouper negatively regulates the interferon response
Zheng, J., Ya, Z., Zhi, L., Lv, S., Xiao, L., Huang, X., Huang, Y., & Qin, Q. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.06.062 · Cited by 17
Lentiviral Effector Pathways of TRIM Proteins
Turrini, F., Pietro, A. D., & Vicenzi, E. (2014) · DNA and Cell Biology · doi:10.1089/dna.2014.2374 · Cited by 17
A non-canonical role for the autophagy machinery in anti-retroviral signaling mediated by TRIM5α
Saha, B., Chisholm, D., Kell, A. M., & Mandell, M. A. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1009017 · Cited by 16
Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS immune sensing
Scott, T. M., Arnold, L. M., Powers, J. A., McCann, D., Rowe, A. B., Christensen, D. E., Pereira, M. J. B., Zhou, W., Torrez, R. M., Iwasa, J., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012206 · Cited by 16
Recognize Yourself—Innate Sensing of Non-LTR Retrotransposons
Lagisquet, J., Zuber, K., & Gramberg, T. (2021) · Viruses · doi:10.3390/v13010094 · Cited by 17
Cellular Restriction Factors of Feline Immunodeficiency Virus
Zielonka, J., & Münk, C. (2011) · Viruses · doi:10.3390/v3101986 · Cited by 16
Pattern Recognition Receptors in HIV Transmission
Mesman, A. W., & Geijtenbeek, T. B. H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00059 · Cited by 17
Nonhuman TRIM5 Variants Enhance Recognition of HIV-1-Infected Cells by CD8 + T Cells
Jiménez‐Moyano, E., Ruiz, A., Kløverpris, H. N., Rodriguez-Plata, M. T., Peña, R., Blondeau, C., Selwood, D. L., Izquierdo‐Useros, N., Moris, A., Clotet, B., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00819-16 · Cited by 16
Exploring Coronary Artery Disease GWAs Targets With Functional Links to Immunometabolism
Hughes, M., Lenighan, Y. M., Godson, C., & Roche, H. M. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00148 · Cited by 16
Lukic, Z., & Campbell, E. M. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0102-8 · Cited by 16
Opposite transcriptional regulation of integrated vs unintegrated HIV genomes by the NF-κB pathway
Thierry, S., Thierry, E., Subra, F., Deprez, E., Leh, H., Bury‐Moné, S., & Delelis, O. (2016) · Scientific Reports · doi:10.1038/srep25678 · Cited by 16
Wei, Y., Zou, C., Zeng, S., Xue, C., & Cao, Y. (2019) · Virus Research · doi:10.1016/j.virusres.2019.197647 · Cited by 16
Pierini, V., Gallucci, L., Stürzel, C. M., Kirchhoff, F., & Fackler, O. (2021) · Journal of Virology · doi:10.1128/jvi.02372-20 · Cited by 16
TRIM5α recruits HDAC1 to p50 and Sp1 and promotes H3K9 deacetylation at the HIV-1 LTR
Ran, X.-H., Zhu, J.-W., Ni, R.-Z., Zheng, Y., Chen, Y.-Y., Zheng, W.-H., & Mu, D. (2023) · Nature Communications · doi:10.1038/s41467-023-39056-6 · Cited by 16
Imam, S., Keceli, S. K., Mattick, J., Selyutina, A., Talley, S., Eddins, A., Diaz‐Griffero, F., & Campbell, E. M. (2019) · Journal of Virology · doi:10.1128/jvi.00558-19 · Cited by 16
Zhu, J.-W., Liu, F., Mu, D., Deng, D., & Zheng, Y. (2017) · Microbes and Infection · doi:10.1016/j.micinf.2017.01.002 · Cited by 15
Jobe, O., Kim, J., Tycksen, E., Onkar, S., Michael, N. L., Alving, C. R., & Rao, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01352 · Cited by 15
E2 conjugating enzymes: A silent but crucial player in ubiquitin biology
Parashar, S., Kaushik, A., Ambasta, R. K., & Kumar, P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102740 · Cited by 14
Dudley-Fraser, J., & Rittinger, K. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1287257 · Cited by 15
Ebola virus VP35 interacts non-covalently with ubiquitin chains to promote viral replication
Rodríguez-Salazar, C. A., van Tol, S., Mailhot, O., González-Orozco, M., Galdino, G. T., Warren, A. N., Teruel, N., Behera, P., Afreen, K. S., Zhang, L., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002544 · Cited by 16
Kelly, J. N., Woods, M. W., Xhiku, S., & Barr, S. D. (2014) · Human Mutation · doi:10.1002/humu.22595 · Cited by 14
Macaque-tropic human immunodeficiency virus type 1: breaking out of the host restriction factors
Saito, A., & Akari, H. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00187 · Cited by 14
Nepveu-Traversy, M.-É., Demogines, A., Fricke, T., Plourde, M. B., Riopel, K., Veillette, M., Diaz‐Griffero, F., Sawyer, S. L., & Berthoux, L. (2016) · Heliyon · doi:10.1016/j.heliyon.2015.e00056 · Cited by 14
Hertoghs, N., Geijtenbeek, T. B. H., & Ribeiro, C. M. S. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.01.001 · Cited by 15
Cyclophilins A and B oppositely regulate renal tubular epithelial cell phenotype
Sarró, E., Durán, M., Rico, A., Bou‐Teen, D., Fernández‐Majada, V., Croatt, A. J., Nath, K. A., Salcedo, M. T., Gundelach, J. H., BATLLE, D. C., et al. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa005 · Cited by 14
Kálai, T., Pongracz, J. E., & Mátyus, P. (2022) · Chemistry · doi:10.3390/chemistry4020019 · Cited by 14
Metadata
- Authors
- Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D., Chatel, L., Bisiaux, A., Albert, M. L., Strambio-De-Castillia, C., Mothes, W., Pizzato, M., Grütter, M. G., & Luban, J.
- Affiliations
- University of Geneva (CH)
- University of Zurich (CH)
- Yale University (US)
- Light Chain Bioscience (Switzerland) (CH)
- Inserm (FR)
- Corresponding author
- Luban, Jeremy
- ORCID
- Venue
- Nature
- Published
- 2011-04
- Volume
- 472
- Issue
- 7343
- Pages
- 361-365
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3081621
- OpenAlex
- W2057040546
- Cited by
- 645
- References
- 27
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 35 · 2023: 27 · 2022: 19 · 2021: 34 · 2020: 39 · 2019: 50 · 2018: 43 · 2017: 41 · 2016: 39 · 2015: 48 · 2014: 56 · 2013: 70 · 2012: 72
- FWCI
- 29.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- SERVAL (Université de Lausanne) (acceptedVersion, other-oa)
- IRIS (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Iris (University of Trento) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (59159, 128655, 122342, 3100A0)
- National Institutes of Health (3100A0-128655)
- National Institute of Allergy and Infectious Diseases (R01 AI59159, R01AI059159, R21AI087467)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TRIM5, antiretroviral restriction factors, E3 ubiquitin ligase, pattern recognition receptors, innate immune signaling, K63-linked ubiquitin, TAK1, NF-κB signaling, retroviral infection
- MeSH terms
- Tripartite Motif Proteins, Antiviral Restriction Factors, MAP Kinase Kinase Kinase 7, Capsid, Carrier Proteins, Cell Line, Enzyme Activation, Humans, Immunity, Innate, Lipopolysaccharides, Protein Binding, Retroviridae, Transcription Factors, Signal Transduction, HIV-1, NF-kappa B, Transcription Factor AP-1, MAP Kinase Kinase Kinases, Ubiquitin, Ubiquitin-Conjugating Enzymes, Ubiquitin-Protein Ligases, Receptors, Pattern Recognition, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review